GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » EV-to-FCF

LungLife AI (LSE:LLAI) EV-to-FCF : -0.96 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, LungLife AI's Enterprise Value is £3.87 Mil. LungLife AI's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was £-4.03 Mil. Therefore, LungLife AI's EV-to-FCF for today is -0.96.

The historical rank and industry rank for LungLife AI's EV-to-FCF or its related term are showing as below:

LSE:LLAI' s EV-to-FCF Range Over the Past 10 Years
Min: -27.74   Med: -2.46   Max: 0.23
Current: -0.96

During the past 6 years, the highest EV-to-FCF of LungLife AI was 0.23. The lowest was -27.74. And the median was -2.46.

LSE:LLAI's EV-to-FCF is ranked worse than
100% of 94 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.03 vs LSE:LLAI: -0.96

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), LungLife AI's stock price is £0.19. LungLife AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.168. Therefore, LungLife AI's PE Ratio for today is At Loss.


LungLife AI EV-to-FCF Historical Data

The historical data trend for LungLife AI's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI EV-to-FCF Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -5.31 -3.20 -2.42

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.31 - -3.20 - -2.42

Competitive Comparison of LungLife AI's EV-to-FCF

For the Diagnostics & Research subindustry, LungLife AI's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LungLife AI's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where LungLife AI's EV-to-FCF falls into.



LungLife AI EV-to-FCF Calculation

LungLife AI's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3.870/-4.032
=-0.96

LungLife AI's current Enterprise Value is £3.87 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LungLife AI's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was £-4.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LungLife AI  (LSE:LLAI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

LungLife AI's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.19/-0.168
=At Loss

LungLife AI's share price for today is £0.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LungLife AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.168.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


LungLife AI EV-to-FCF Related Terms

Thank you for viewing the detailed overview of LungLife AI's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


LungLife AI (LSE:LLAI) Business Description

Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines